Misquoted: Experts clarify on Lancet study claiming protection offered by Covishield declines after 3 months Ruchika Sharma25 Dec 2021 3:40 PM ISTNew Delhi: The Lancet study, which reportedly states that the protection offered by the Oxford AstraZeneca Covid-19 vaccine Covishield declines after...
Roche at-home COVID rapid test gets USFDA approval Ruchika Sharma25 Dec 2021 1:01 PM ISTBasel: Roche has recently announced that the U.S. Food and Drug Administration (USFDA) has granted Emergency Use Authorization (EUA) for its...
Covishield protection diminishes after 3 months, says Lancet study Roshni Dhar25 Dec 2021 12:18 PM ISTThe protection offered by the Oxford-Astra Zeneca COVID-19 vaccine declines after three months of receiving two doses of the preventive, according to...
87 fully vaccinated, 3 with even booster dose test positive for Omicron: Govt Medical Dialogues Bureau25 Dec 2021 9:45 AM ISTBhushan said 121 cases had foreign travel history, while in 44 cases the infected had come in contact with foreign travellers and information about 18...
Amid rise in Omicron cases, Centre launches study to assess need for booster dose MD Bureau25 Dec 2021 9:45 AM ISTThe study is expected to cover all three vaccines used in India, Covishield, Covaxin and Sputnik V.
Health Bulletin 24/December/2021 Roshni Dhar24 Dec 2021 6:00 PM ISTHere are Top Health stories of the dayDoctors Indemnity Not For Hospital: Supreme CourtThe Supreme Court has recently observed that if a hospital is...
Why third dose might be needed for Omicron? Dr. Nandita Mohan24 Dec 2021 2:48 PM IST A team of researchers from Hong Kong University (HKU) has given an explanation on why the Omicron variant of the SARS-CoV-2 virus transmits...
Finally Molnupiravir gets USFDA nod Ruchika Sharma24 Dec 2021 11:36 AM ISTKenilworth: A day after Pfizer's Paxlovid bagged the U.S. Food and Drug Administration (USFDA) Emergency Use Authorization (EUA) nod, Merck's...
Serum Institute waives indemnity over AstraZeneca COVID vaccine for refugees Ruchika Sharma24 Dec 2021 9:00 AM ISTNew Delhi: The Serum Institute of India (SII) has waived its protection from legal liabilities for any AstraZeneca-Oxford COVID-19 shots it supplies...
Booster dose of AstraZeneca COVID vaccine effective against Omicron Ruchika Sharma23 Dec 2021 3:52 PM ISTUK: Citing the Oxford University lab study , drug major AstraZeneca has announced that the booster dose of the company's COVID vaccine Vaxzevria...
Pfizer COVID drug Paxlovid gets USFDA emergency use nod Ruchika Sharma23 Dec 2021 12:54 PM ISTNew York: Pfizer Inc. has recently announced that the U.S. Food and Drug Administration (FDA) has authorized the emergency use of PAXLOVID...
WHO advisory group issues interim recommendations for Covovax use Ruchika Sharma23 Dec 2021 10:00 AM ISTGaithersburg: Novavax, Inc. has announced that the World Health Organization (WHO) Strategic Advisory Group of Experts on Immunization...
